Molecular pathways in head and neck cancer: EGFR, PI3K, and more

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

Volumn , Issue , 2013, Pages 246-255

  Psyrri, Amanda ^a   Seiwert, Tanguy Y ^a   Jimeno, Antonio ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR 2; ACVRL1 PROTEIN, HUMAN; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; NOTCH1 PROTEIN, HUMAN; NOTCH1 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; SONIC HEDGEHOG PROTEIN;

ANTAGONISTS AND INHIBITORS; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; HEAD AND NECK NEOPLASMS; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; MUTATION; PATHOLOGY; PROCEDURES; SIGNAL TRANSDUCTION;

ACTIVIN RECEPTORS, TYPE II; CETUXIMAB; EPITHELIAL-MESENCHYMAL TRANSITION; HEAD AND NECK NEOPLASMS; HEDGEHOG PROTEINS; HUMANS; MOLECULAR TARGETED THERAPY; MUTATION; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION;

EID: 84979673540     PISSN: None     EISSN: 15488756     Source Type: Journal    
DOI: 10.1200/EdBook_AM.2013.33.246     Document Type: Review

References (0)